Characteristic - n (%) | Non-users (mean ± SD, n=7) | Steroid users (mean ± SD, n=14) | All patients (mean ± SD, n=21) | P value |
---|---|---|---|---|
Age - years | 29.4 (6.4) | 29.9 (5.1) | 29.7 (5.4) | 0.841 |
Male - n (%) | 7 (100) | 13 (92.9) | 20 (95.2) | 0.469 |
Rest HR - min-1 | 57.9 (4.4) | 67.0 (10.8) | 64.0 (10.1) | 0.047 |
Stress HR - min-1 | 88.2 (10.3) | 92.4 (13.9) | 91.1 (12.8) | 0.516 |
Rest mean BP - mmHg | 87.0 (14.0) | 92.3 (13.5) | 90.6 (13.5) | 0.415 |
Stress mean BP - mmHg | 87.4 (12.1) | 96.8 (17.9) | 94.0 (16.6) | 0.256 |
LV-EDV index - ml/m2 | 91.3 (9.9) | 95.5 (13.0) | 94.1 (12.0) | 0.466 |
LV-ESV index - ml/m2 | 34.3 (5.7) | 37.5 (6.9) | 36.5 (6.9) | 0.306 |
LV ejection fraction - % | 62.4 (3.6) | 61.1 (2.7) | 61.5 (2.7) | 0.343 |
LV mass index - g/m2 | 79.5 (13.4) | 101.8 (14.4) | 94.4 (17.5) | 0.003 |
Max wall thickness | 9.6 (1.3) | 13.2 (2.1) | 12.0 (2.5) | <0.001 |
Late gadolinium enhancement | 0 (0) | 0 (0) | 0 (100) | - |